IIR’s Forced Degradation Forum is returning and updated with ALL NEW information and updates on the latest forced degradation insights and advances. Over the last six years, IIR’s Forced Degradation conferences have become catalysts for scientific progress and improvements in forced degradation testing and analysis. Join IIR and event co-founders Karen Alsante (Pfizer) and Steve Baertschi (Eli Lilly), for another ground-breaking event that addresses the latest challenges at the 6th annual Forced Degradation Forum.
Explore What’s New NOW in Forced Degradation
→ Dive deeper into practical solutions & experimental tools for oxidation, photostability, and chemical reactions
→ Generate valuable insight into the potential for forming genotoxic degradants to support proactive strategies to control them
→ Uncover the latest advances in software to predict forced degradation to enrich the interpretation of experimental results.
→ Expand the effectiveness of individual scientists through the use of new software resources
→ Tap into the newest concepts in stress testing to improve performance and efficiency
→ Discover new tools to conduct automated FD in early & late phases
We look forward to seeing you in Philadelphia!
Register before January 8th and Save $400 when you mention code 0IY73U
Forced Degradation Forum
Web Seminar
Title: Offshoring to Emerging Countries: Navigating Uncertain Waters
Date: Thursday, January 21, 2010
Time: 2:00 PM - 3:00 PM EST
Mention priority code: P1500W2BlogTwitter
Presented by:
Jacquie Mardell
Sr Director Clinical Operations
Metabolex
Sign up for the complimentary webinar here.
Date: Thursday, January 21, 2010
Time: 2:00 PM - 3:00 PM EST
Mention priority code: P1500W2BlogTwitter
Presented by:
Jacquie Mardell
Sr Director Clinical Operations
Metabolex
Sign up for the complimentary webinar here.
Blog Archive
-
▼
2009
(203)
-
►
December
(29)
- Complimentary Web Seminar: Offshoring to Emerging ...
- Happy Holidays from Partnerships in Clinical Trial...
- Complimentary Web Seminar: Offshoring to Emerging ...
- Central Labs Spotlight: Craig Lipset , Pfizer
- Attend Central Labs on us!
- Partnerships keynote speaker Ethan Zohn's cancer i...
- Attend Partnerships in Clinical Trials as a Guest ...
- Central Labs Spotlight: Guy Mascaro and Linda Sull...
- Covance expanding in Asia-Pacific
- How open innovation could reinvigorate the pharmac...
- Would you like to guest blog from Partnerships in ...
- Rules-Based Medicine and Psynova Neurotech Announc...
- Thank you from Partnerships in Clinical Trials Asi...
- Partnerships in Clinical Trials Asia Pacific: Focu...
- Partnerships in Clinical Trials Asia Pacific: Focu...
- Partnerships in Clinical Trials Asia Pacific: Focu...
- Partnerships in Clinical Trials Asia Pacific: Tail...
- Partnerships in Clinical Trials Asia Pacific: The ...
- Partnerships in Clinical Trials Asia Pacific: How ...
- Partnerships in Clinical Trials Asia Pacific: Regi...
- Partnerships in Clinical Trials Asia Pacific: A Da...
- Partnerships in Clinical Trials Asia Pacific: Acce...
- Partnerships in Clinical Trials Asia Pacific: Stra...
- Partnerships in Clinical Trials Asia Pacific: Find...
- Partnerships in Clinical Trials Asia Pacific: Outs...
- Partnerships in Clinical Trials Asia Pacific: Asia...
- Partnerships in Clinical Trials Asia Pacific: New ...
- Partnerships in Clinical Trials Asia Pacific: Welc...
- Central Labs Speaker Profile: Dr. James D Watson
-
▼
November
(9)
- Covance Partners with RBM to Extend Biomarker Offe...
- Forced Degradation Brochure Now Available
- Call for Bloggers: Attend Partnerships in Clinical...
- Forced Degradation Forum Brochure Available
- Contract Research Remains Strong According to F&S ...
- A new way to find potential clinical trial partici...
- Partnerships In Clinical Trials Expands Its Global...
- Malaria vaccine trail to begin in east Africa
- Florida Senator wants to see clinical trial expens...
-
►
October
(8)
- PPD Makes Significant Inroad into China Biotech wi...
- Studies may be failing to show adverse effects of ...
- Genzyme begins Phase 3 clinical trial
- Amarin Appoints Medpace as CRO for Two Phase 3 Car...
- Top 5 Clinical Trial Partnering in Asia Pacific Qu...
- Kansas Cancer Center to Join Clinical Trials
- New guidance draft document for REMS
- Adaptive Clinical Trials Benefit Smaller Laborator...
-
►
December
(29)













0 comments:
Post a Comment